• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Sema4 to Participate in Upcoming Investor Conferences

    5/24/21 7:00:00 AM ET
    $CMLF
    Business Services
    Finance
    Get the next $CMLF alert in real time by email

    Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced that members of the Sema4 management team will participate in fireside chats at two upcoming virtual investor conferences. Eric Schadt, PhD, Founder and Chief Executive Officer, and Isaac Ro, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 and the Goldman Sachs Annual Global Healthcare Conference on Tuesday, June 8, 2021.

    Event: Jefferies Virtual Healthcare Conference

    Date: Friday, June 4, 2021

    Time: 11:00 a.m. ET / 8:00 a.m. PT

    Event: Goldman Sachs Annual Global Healthcare Conference

    Date: Tuesday, June 8, 2021

    Time: 1:20 p.m. ET / 10:20 a.m. PT

    Following each conference, a Form 8-K with a copy of the transcript will be filed with the U.S. Securities and Exchange Commission (SEC). A link to the SEC filing will be available on the Company's website at https://sema4.com/our-story/investors/.

    About Sema4

    Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all. For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005245/en/

    Get the next $CMLF alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMLF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CMLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sherman Rachel E.

    4 - Sema4 Holdings Corp. (0001818331) (Issuer)

    10/19/21 7:31:01 PM ET
    $CMLF
    Business Services
    Finance

    SEC Form 4 filed by Turner Nat

    4 - Sema4 Holdings Corp. (0001818331) (Issuer)

    10/19/21 7:29:25 PM ET
    $CMLF
    Business Services
    Finance

    SEC Form 4 filed by Pellini Michael J

    4 - Sema4 Holdings Corp. (0001818331) (Issuer)

    10/19/21 7:27:37 PM ET
    $CMLF
    Business Services
    Finance

    $CMLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights

    37% increase in fourth quarter test volumes (excluding COVID-19 tests) compared to the same period last year Record quarterly test volume of nearly 83,000 24% growth in fourth quarter revenue (excluding COVID-19 tests) compared to the same period last year Reiterating full year 2022 total revenue guidance of $215-225 million Sema4 to host conference call today at 4:30 p.m. ET STAMFORD, Conn., March 14, 2022 (GLOBE NEWSWIRE) -- Sema4 Holdings Corp. (NASDAQ:SMFR) ("Sema4"), an AI-driven genomic and clinical data intelligence platform company, today reported its financial results for the fourth quarter and full year ended December 31, 2021 and provided an update on key strategic and ope

    3/14/22 4:05:00 PM ET
    $CMLF
    $SMFR
    Business Services
    Finance
    Retail: Computer Software & Peripheral Equipment
    Technology

    Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company

    Sema4 Holdings Corp ("Sema4") to debut on Nasdaq as a publicly traded company dedicated to transforming healthcare by applying artificial intelligence and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human healthBusiness combination expected to result in ~$500 million in cash proceeds to Sema4 to accelerate organic and inorganic growthCombined company to trade on Nasdaq under ticker "SMFR" STAMFORD, Conn., July 22, 2021 (GLOBE NEWSWIRE) -- Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the completion of its business combination with CM Life

    7/22/21 9:15:41 AM ET
    $TWST
    $MGTA
    $CMLF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Business Services

    Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors

    Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of renowned executive Jason Ryan to its Board of Directors. Mr. Ryan will begin serving on Sema4's Board of Directors upon his official appointment after Sema4 closes its previously announced business combination with CM Life Sciences (NASDAQ:CMLF), a special purpose acquisition company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210707005228/en/Jason Ryan (Photo: Business Wire) Mr. Ryan most recently served as Chief Operating and Financial Officer of Magenta Therapeutics (NA

    7/7/21 7:00:00 AM ET
    $TWST
    $CMLF
    $MGTA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Business Services
    Finance

    $CMLF
    SEC Filings

    View All

    SEC Form 424B3 filed by CM Life Sciences, Inc.

    424B3 - Sema4 Holdings Corp. (0001818331) (Filer)

    10/14/21 9:58:15 PM ET
    $CMLF
    Business Services
    Finance

    CM Life Sciences, Inc. filed SEC Form 8-K: Leadership Update

    8-K - Sema4 Holdings Corp. (0001818331) (Filer)

    10/14/21 5:23:09 PM ET
    $CMLF
    Business Services
    Finance

    SEC Form S-8 filed by CM Life Sciences, Inc.

    S-8 - Sema4 Holdings Corp. (0001818331) (Filer)

    9/27/21 4:46:23 PM ET
    $CMLF
    Business Services
    Finance

    $CMLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by CM Life Sciences, Inc.

    SC 13D - Sema4 Holdings Corp. (0001818331) (Subject)

    10/13/21 2:31:34 PM ET
    $CMLF
    Business Services
    Finance

    SEC Form SC 13D filed by CM Life Sciences, Inc.

    SC 13D - Sema4 Holdings Corp. (0001818331) (Subject)

    8/30/21 4:45:58 PM ET
    $CMLF
    Business Services
    Finance

    SEC Form SC 13D filed by CM Life Sciences, Inc.

    SC 13D - Sema4 Holdings Corp. (0001818331) (Subject)

    8/2/21 4:59:57 PM ET
    $CMLF
    Business Services
    Finance

    $CMLF
    Leadership Updates

    Live Leadership Updates

    View All

    Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer

    Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of Andrew Kasarskis, PhD, to the newly established role of Chief Data Officer (CDO). Dr. Kasarskis brings more than 20 years of leadership and broad experience in industry and academia that includes a strong focus on digital analytics and genomics and internationally recognized research in the life sciences. At Sema4, he will be responsible for establishing additional structures and processes to further optimize the company's health intelligence platform and orchestrating data use and data science to support research, development, and innov

    6/17/21 7:00:00 AM ET
    $CMLF
    Business Services
    Finance

    $CMLF
    Financials

    Live finance-specific insights

    View All

    Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights

    37% increase in fourth quarter test volumes (excluding COVID-19 tests) compared to the same period last year Record quarterly test volume of nearly 83,000 24% growth in fourth quarter revenue (excluding COVID-19 tests) compared to the same period last year Reiterating full year 2022 total revenue guidance of $215-225 million Sema4 to host conference call today at 4:30 p.m. ET STAMFORD, Conn., March 14, 2022 (GLOBE NEWSWIRE) -- Sema4 Holdings Corp. (NASDAQ:SMFR) ("Sema4"), an AI-driven genomic and clinical data intelligence platform company, today reported its financial results for the fourth quarter and full year ended December 31, 2021 and provided an update on key strategic and ope

    3/14/22 4:05:00 PM ET
    $CMLF
    $SMFR
    Business Services
    Finance
    Retail: Computer Software & Peripheral Equipment
    Technology